目次

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR’s internal database
1.1.3 Secondary sources:
1.1.4 Third Party Perspective:
1.1.5 Primary Research:
1.2 Information or Data Analysis
1.3 Market Formulation & Validation
1.4 Region Wise Market Calculation
1.4.1 Region wise market: Base estimates
1.4.2 Global market: CAGR calculation
1.4.3 Region based segment share calculation

Chapter 2 Executive Summary
2.1 Market Outlook

Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/ancillary market outlook
3.2 Cost Structure Analysis
3.3 User Perspective Analysis
3.3.1 Consumer behavior analysis
3.3.2 Market influencer analysis
3.4 Procedure Cost Analysis
3.5 List of Key End-users
3.6 Technology Overview
3.6.1 Technology timeline
3.7 Impact of COVID-19 Pandemic
3.7.1 Impact on the supply chain
3.7.2 Association of COVID-19 with next-generation sequencing
3.8 Market Segmentation & Scope
3.8.1 Market driver analysis
3.8.1.1 Exponentially decreasing costs for genetic sequencing
3.8.1.2 Development of companion diagnostics and personalized medicine
3.8.1.3 Rise in competition amongst prominent market entities
3.8.1.4 Rising clinical opportunity for NGS technology
3.8.1.5 Technological advancements in cloud computing and data integration
3.8.1.6 Growing healthcare expenditure supporting the development of effective PM diagnostic & therapeutic procedures for cancer
3.8.1.7 Increasing prevalence of cancer
3.8.2 Market restraint analysis
3.8.2.1 Lack of computational efficiency for data management
3.8.2.2 Non-value based NGS reimbursement policy and regulation status
3.8.2.3 Challenges associated with NGS implementation
3.9 Penetration & Growth Prospect Mapping for Applications, 2019
3.10 Penetration & Growth Prospect Mapping for Prominent Industry Players, 2019
3.11 NGS Platform Penetration Mapping, 2019
3.11.1 Next-generation sequencing reimbursement environment
3.11.2 Gap-fill approach for reimbursement of NGS tests
3.11.3 Role of the commercial payers
3.11.3.1 Payer perspectives for developing coverage policy for Next-Generation Tumor Sequencing Panels (NGTS)
3.11.3.2 Role of diagnostic laboratories and pathology centers
3.11.4 North America
3.11.4.1 U.S.
3.11.4.2 Canada
3.11.5 Europe
3.11.5.1 U.K.
3.11.5.2 Germany
3.11.5.3 Spain
3.11.6 Asia Pacific
3.11.7 Latin America
3.11.8 Middle East Africa
3.11.9 Next-Generation Sequencing Market: Regional Market Share, 2021
3.12 Next-Generation Sequencing Regulatory and Political Environment
3.12.1 Next-Generation Sequencing North America Regulatory and Political Landscape Analysis, 2021
3.12.1.1 U.S.
3.12.1.2 Canada
3.12.2 Next-Generation Sequencing Europe Regulatory and Political Landscape Analysis, 2021
3.12.2.1 U.K.
3.12.2.2 Germany
3.12.2.3 France
3.12.2.4 Spain
3.12.3 Next-Generation Sequencing Asia Pacific Regulatory and Political Landscape Analysis, 2021
3.12.3.1 Japan
3.12.3.2 China
3.12.4 Next-Generation Sequencing Latin America Regulatory and Political Landscape Analysis, 2021
3.12.4.1 Brazil
3.12.4.2 Mexico
3.12.4.3 Argentina
3.12.5 Next-Generation Sequencing Middle East & Africa Regulatory and Political Landscape Analysis, 2021
3.12.5.1 South Africa
3.12.5.2 Qatar
3.12.5.3 Kuwait
3.12.5.4 UAE
3.12.5.5 Saudi Arabia
3.13 Next-Generation Sequencing - SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
3.14 Industry Analysis - Porter’s
3.14.1 Major deals & strategic alliances analysis
3.14.1.1 Joint ventures
3.14.1.2 Mergers & acquisitions
3.14.1.3 Licensing & partnership
3.14.2 Technology collaborations
3.15 Market Entry Strategies
3.16 Case Studies
3.16.1 Impact of NGS on Treatment Selection in acute myeloid leukemia (AML)

Chapter 4 Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company Categorization
4.3 Public Companies
4.3.1 List of key distributors and channel partners
4.3.1.1 Service providers, manufacturers, & suppliers of products
4.3.1.2 Key distributors and channel partners of Illumina
4.3.1.2.1 Americas (North, South, & Central America)
4.3.1.2.2 Europe
4.3.1.2.3 Asia/Central Pacific
4.3.1.2.4 Middle East & Africa
4.3.1.3 Service providers of ThermoFisher
4.3.1.3.1 North America
4.3.1.3.2 EMEA
4.3.1.3.3 Asia Pacific
4.3.2 Key customers
4.3.3 Key company market share analysis, 2019
4.3.3.1 Company size
4.3.3.2 Geographical presence
4.3.3.3 Product portfolio
4.3.4 Competitive dashboard analysis
4.3.5 Market differentiators
4.3.6 Private companies
4.3.6.1 List of emerging players
4.3.6.2 Funding outlook
4.3.6.3 Regional network map
4.3.6.4 Company market position analysis, 2019
4.3.6.5 List of suppliers

Chapter 5 NGS Application Estimates & Trend Analysis
5.1 Next-Generation Sequencing Market: Application Movement Analysis
5.2 Oncology
5.2.1 Global oncology market, 2018 - 2030 (USD Million)
5.2.2 Diagnostics and screening
5.2.2.1 Diagnostics and screening market, 2018 - 2030 (USD Million)
5.2.2.2 Oncology screening
5.2.2.2.1 Oncology screening market, 2018 - 2030 (USD Million)
5.2.2.2.2 Sporadic cancer screening market, 2018 - 2030 (USD Million)
5.2.2.2.3 Inherited cancer screening market, 2018 - 2030 (USD Million)
5.2.2.3 Companion diagnostics
5.2.2.3.1 Companion diagnostics market, 2018 - 2030 (USD Million)
5.2.2.4 Other diagnostics
5.2.2.4.1 Other diagnostics market, 2018 - 2030 (USD Million)
5.2.3 Research studies
5.2.3.1 Research studies market, 2018 - 2030 (USD Million)
5.3 Clinical Investigation
5.3.1 Global clinical investigation market, 2018 - 2030 (USD Million)
5.3.2 Infectious diseases
5.3.2.1 Global infectious diseases market, 2018 - 2030 (USD Million)
5.3.3 Inherited diseases
5.3.3.1 Global inherited diseases market, 2018 - 2030 (USD Million)
5.3.4 Idiopathic diseases
5.3.4.1 Global idiopathic diseases market, 2018 - 2030 (USD Million)
5.3.5 Non-communicable/other diseases
5.3.5.1 Global non-communicable/other diseases market, 2018 - 2030 (USD Million)
5.4 Reproductive Health
5.4.1 Global reproductive health market, 2018 - 2030 (USD Million)
5.4.2 NIPT
5.4.2.1 Global NIPT market, 2018 - 2030 (USD Million)
5.4.2.2 Aneuploidy
5.4.2.2.1 Global aneuploidy market, 2018 - 2030 (USD Million)
5.4.2.3 Microdeletions
5.4.2.3.1 Global microdeletions market, 2018 - 2030 (USD Million)
5.4.3 PGT
5.4.3.1 Global NGS PGT market, 2018 - 2030 (USD Million)
5.4.4 New-born/genetic screening
5.4.4.1 Global newborn/genetic screening market, 2018 - 2030 (USD Million)
5.4.5 Single gene analysis
5.4.5.1 Single gene analysis market, 2018 - 2030 (USD Million)
5.5 HLA Typing/Immune System Monitoring
5.5.1 Global HLA typing/immune system monitoring market, 2018 - 2030 (USD Million)
5.6 Metagenomics, Epidemiology & Drug Development
5.6.1 Global metagenomics, epidemiology & drug development market, 2018 - 2030 (USD Million)
5.7 Agrigenomics & Forensics
5.7.1 Global agrigenomics & forensics market, 2018 - 2030 (USD Million)
5.8 Consumer Genomics
5.8.1 Global consumer genomics market, 2018 - 2030 (USD Million)

Chapter 6 NGS Technology Estimates & Trend Analysis
6.1 Next-Generation Sequencing Market: Technology Movement Analysis
6.2 Whole Genome Sequencing
6.2.1 Global whole genome sequencing market, 2018 - 2030 (USD Million)
6.3 Whole Exome Sequencing
6.3.1 Global whole exome sequencing market, 2018 - 2030 (USD Million)
6.4 Targeted Sequencing & Resequencing
6.4.1 Global targeted sequencing & resequencing market, 2018 - 2030 (USD Million)
6.4.2 DNA-based targeted sequencing & resequencing
6.4.2.1 Global DNA-based targeted sequencing & resequencing market, 2018 - 2030 (USD Million)
6.4.3 RNA-based targeted sequencing & resequencing
6.4.3.1 Global RNA-based targeted sequencing & resequencing market, 2018 - 2030 (USD Million)

Chapter 7 NGS Workflow Estimates & Trend Analysis
7.1 Next-Generation Sequencing Market: Workflow Movement Analysis
7.2 Pre-Sequencing
7.2.1 Global pre-sequencing market, 2018 - 2030 (USD Million)
7.2.2 NGS library preparation kits
7.2.2.1 Global NGS library preparation kits market, 2018 - 2030 (USD Million)
7.2.3 NGS semi-automated library preparation
7.2.3.1 Global NGS semi-automated library preparation market, 2018 - 2030 (USD Million)
7.2.4 NGS automated library preparation
7.2.4.1 Global NGS automated library preparation market, 2018 - 2030 (USD Million)
7.2.5 Clonal amplification
7.2.5.1 Global clonal amplification market, 2018 - 2030 (USD Million)
7.3 Sequencing
7.3.1 Global sequencing market, 2018 - 2030 (USD Million)
7.4 Data Analysis
7.4.1 Global data analysis market, 2018 - 2030 (USD Million)
7.4.2 NGS primary data analysis
7.4.2.1 Global NGS primary data analysis market, 2018 - 2030 (USD Million)
7.4.3 NGS secondary data analysis
7.4.3.1 Global NGS secondary data analysis market, 2018 - 2030 (USD Million)
7.4.4 NGS tertiary data analysis
7.4.4.1 Global NGS tertiary data analysis services market, 2018 - 2030 (USD Million)

Chapter 8 NGS End-use Estimates & Trend Analysis
8.1 Next-Generation Sequencing Market: End-Use Movement Analysis
8.2 Academic Research
8.2.1 Global academic research market, 2018 - 2030 (USD Million)
8.3 Clinical Research
8.3.1 Global clinical research market, 2018 - 2030 (USD Million)
8.4 Hospitals & Clinics
8.4.1 Global hospitals & clinics market2018 - 2030 (USD Million)
8.5 Pharma & Biotech Entities
8.5.1 Global pharma & biotech entities market, 2018 - 2030 (USD Million)
8.6 Other Users
8.6.1 Global other users market, 2018 - 2030 (USD Million)

Chapter 9 NGS Regional Estimates & Trend Analysis, by Product & Service Type, Application, Technology, Workflow, & End-use
9.1 Next generation sequencing market share by region, 2019 & 2027
9.2 Regional Market Share and Leading Players, 2019
9.3 North America
9.3.1 North America next-generation sequencing market, 2018 - 2030 (USD Million)
9.3.2 U.S.
9.3.2.1 U.S. next-generation sequencing market, 2018 - 2030 (USD Million)
9.3.3 Canada
9.3.3.1 Canada next-generation sequencing market, 2018 - 2030 (USD Million)
9.4 Europe
9.4.1 Europe next-generation sequencing market, 2018 - 2030 (USD Million)
9.4.2 Germany
9.4.2.1 Germany next-generation sequencing market, 2018 - 2030 (USD Million)
9.4.3 U.K.
9.4.3.1 U.K. next-generation sequencing market, 2018 - 2030 (USD Million)
9.4.4 France
9.4.4.1 France next-generation sequencing market, 2018 - 2030 (USD Million)
9.4.5 Spain
9.4.5.1 Spain next-generation sequencing market, 2018 - 2030 (USD Million)
9.4.6 Italy
9.4.6.1 Italy next-generation sequencing market, 2018 - 2030 (USD Million)
9.5 Asia Pacific
9.5.1 Asia Pacific next-generation sequencing market, 2018 - 2030 (USD Million)
9.5.2 Japan
9.5.2.1 Japan next-generation sequencing market, 2018 - 2030 (USD Million)
9.5.3 China
9.5.3.1 China next-generation sequencing market, 2018 - 2030 (USD Million)
9.5.4 India
9.5.4.1 India next-generation sequencing market, 2018 - 2030 (USD Million)
9.5.5 Australia
9.5.5.1 Australia next-generation sequencing market, 2018 - 2030 (USD Million)
9.5.6 South Korea
9.5.6.1 South Korea next-generation sequencing market, 2018 - 2030 (USD Million)
9.6 Latin America
9.6.1 Latin America next-generation sequencing market, 2018 - 2030 (USD Million)
9.6.2 Brazil
9.6.2.1 Brazil next-generation sequencing market, 2018 - 2030 (USD Million)
9.6.3 Mexico
9.6.3.1 Mexico next-generation sequencing market, 2018 - 2030 (USD Million)
9.7 Middle East & Africa
9.7.1 Middle East & Africa next-generation sequencing market, 2018 - 2030 (USD Million)
9.7.2 South Africa
9.7.2.1 South Africa next-generation sequencing market, 2018 - 2030 (USD Million)
9.7.3 Saudi Arabia
9.7.3.1 Saudi Arabia next-generation sequencing market, 2018 - 2030 (USD Million)

Chapter 10 Competitive Landscape
10.1. Strategy Framework
10.2. Market Participation Categorization
10.3. Next-Generation Sequencing Vendor’s Landscape
10.4. Champions
10.5. Innovators
10.6. Emerging players
10.7. Market pillars
10.8. Company Profiles
10.8.1 Illumina, Inc.
10.8.1.1 Company overview
10.8.1.2 Financial performance
10.8.1.3 Product benchmarking
10.8.1.4 Strategic initiatives
10.8.2 F. Hoffmann-La Roche Ltd.
10.8.2.1 Company overview
10.8.2.2 Financial performance
10.8.2.3 Product benchmarking
10.8.2.4 Strategic initiatives
10.8.3 Agilent Technologies, Inc.
10.8.3.1 Company overview
10.8.3.2 Financial performance
10.8.3.3 Product benchmarking
10.8.3.4 Strategic initiatives
10.8.4 PierianDx
10.8.4.1 Company overview
10.8.5 Tute Genomics
10.8.5.1 Company overview
10.8.6 Knome, Inc.
10.8.6.1 Company overview
10.8.6.2 Financial performance
10.8.6.3 Product benchmarking
10.8.6.4 Strategic initiatives
10.8.7 Intrexon Bioinformatics Germany GmbH
10.8.7.1 Company overview
10.8.7.2 Financial performance
10.8.7.3 Product benchmarking
10.8.7.4 Strategic initiatives
10.8.8 Eurofins Scientific
10.8.8.1 Company overview
10.8.8.2 Eurofins GATC Biotech GmbH
10.8.8.2.1 Company overview
10.8.8.3 Financial performance
10.8.8.3.1 Financial performance: Eurofins GATC Biotech GmbH
10.8.8.4 Product benchmarking
10.8.8.5 Strategic initiatives
10.8.9 Oxford Nanopore Technologies
10.8.9.1 Company overview
10.8.9.2 Financial performance
10.8.9.3 Product benchmarking
10.8.9.4 Strategic initiatives
10.8.10 Macrogen, Inc.
10.8.10.1 Company overview
10.8.10.2 Financial performance
10.8.10.3 Product benchmarking
10.8.10.4 Strategic initiatives
10.8.11 DNASTAR, Inc.
10.8.11.1 Company overview
10.8.11.2 Financial Performance
10.8.11.3 Product benchmarking
10.8.11.4 Strategic initiatives
10.8.12 Thermo Fisher Scientific, Inc.
10.8.12.1 Company overview
10.8.12.1.1 Life Technologies Corp.
10.8.12.2 Financial performance
10.8.12.3 Product benchmarking
10.8.12.4 Strategic initiatives
10.8.13 Biomatters Ltd.
10.8.13.1 Company overview
10.8.13.2 Financial performance
10.8.13.3 Product benchmarking
10.8.13.4 Strategic initiatives
10.8.14 QIAGEN
10.8.13 Ingenuity
10.8.14 CLC Bio
10.8.14.1 Company overview
10.8.14.2 Financial performance
10.8.14.2 Financial performance
10.8.14.3 Product benchmarking
10.8.14.4 Strategic initiatives
10.8.15 BGI
10.8.15.1 Complete Genomics Incorporated
10.8.15.1.1 Company overview
10.8.15.1.2 Financial performance
10.8.15.1.3 Product benchmarking
10.8.15.1.4 Strategic initiatives
10.8.16 Perkin Elmer, Inc.
10.8.16.1 Company overview
10.8.16.2 PERKINELMER GENOMICS
10.8.16.3 Financial performance
10.8.16.4 Product benchmarking
10.8.16.5 Strategic initiatives
10.8.17 Pacific Biosciences of California, Inc.
10.8.17.1 Company overview
10.8.17.2 Financial performance
10.8.17.3 Product benchmarking
10.8.17.4 Strategic initiatives
10.8.18 Partek Incorporated
10.8.18.1 Company overview
10.8.18.2 Financial performance
10.8.18.3 Product benchmarking
10.8.18.4 Strategic initiatives
10.8.19 Bio-Rad Laboratories, Inc.
10.8.19.1 Company overview
10.8.20 GnuBio
10.8.20.1 Company overview
10.8.20.2 Financial performance
10.8.20.3 Product benchmarking
10.8.20.4 Strategic initiatives
10.8.21 Myriad Genetics, Inc.
10.8.21.1 Company overview
10.8.21.2 Financial performance
10.8.21.3 Product benchmarking
10.8.21.4 Strategic initiatives
10.8.22 Hologic, Inc. (Gen-Probe Incorporated)
10.8.22.1 Company overview
10.8.22.2 Financial performance
10.8.22.3 Product benchmarking
10.8.22.4 Strategic initiatives
10.8.23 Horizon Discovery Group plc
10.8.23.1 Company overview
10.8.23.2 Financial performance
10.8.23.3 Product benchmarking
10.8.23.4 Strategic initiatives
10.8.24 LGC Limited
10.8.24.1 Company overview
10.8.25 SeraCare
10.8.25.1 Company overview
10.8.25.2 Financial performance (LGC Limited)
10.8.25.3 Product benchmarking
10.8.25.4 Strategic initiatives
10.8.26 Vela Diagnostics
10.8.26.1 Company overview
10.8.26.2 Financial performance
10.8.26.3 Product benchmarking
10.8.26.4 Strategic initiatives

List of Tables
TABLE 1 List of Secondary Sources
TABLE 2 Country share estimation
TABLE 3 Healthcare expenditure, 2015
TABLE 4 NGS top platforms
TABLE 5 Base pairs sequenced using WGS, WES, and targeted sequencing & resequencing
TABLE 6 Clonal amplification products in the market
TABLE 7 North America next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 8 North America next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 9 North America next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 10 North America next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 11 North America NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 12 North America NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 13 North America next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 14 North America next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 15 North America targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 16 North America next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 17 North America NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 18 North America NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 19 North America next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 20 U.S. next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 21 U.S. next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 22 U.S. next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 23 U.S. next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 24 U.S. NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 25 U.S. NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 26 U.S. next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 27 U.S. next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 28 U.S. targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 29 U.S. next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 30 U.S. NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 31 U.S. NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 32 U.S. next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 33 Canada next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 34 Canada next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 35 Canada next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 36 Canada next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 37 Canada NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 38 Canada NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 39 Canada next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 40 Canada next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 41 Canada targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 42 Canada next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 43 Canada NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 44 Canada NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 45 Canada next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 46 Europe next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 47 Europe next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 48 Europe next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 49 Europe next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 50 Europe NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 51 Europe NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 52 Europe next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 53 Europe next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 54 Europe targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 55 Europe next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 56 Europe NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 57 Europe NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 58 Europe next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 59 Germany next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 60 Germany next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 61 Germany next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 62 Germany next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 63 Germany NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 64 Germany NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 65 Germany next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 66 Germany next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 67 Germany targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 68 Germany next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 69 Germany NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 70 Germany NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 71 Germany next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 72 U.K. next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 73 U.K. next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 74 U.K. next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 75 U.K. next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 76 U.K. NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 77 U.K. NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 78 U.K. next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 79 U.K. next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 80 U.K. targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 81 U.K. next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 82 U.K. NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 83 U.K. NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 84 U.K. next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 85 Spain next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 86 Spain next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 87 Spain next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 88 Spain next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 89 Spain NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 90 Spain NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 91 Spain next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 92 Spain next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 93 Spain targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 94 Spain next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 95 Spain NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 96 Spain NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 97 Spain next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 98 France next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 99 France next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 100 France next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 101 France next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 102 France NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 103 France NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 104 France next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 105 France next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 106 France targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 107 France next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 108 France NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 109 France NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 110 France next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 111 Italy next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 112 Italy next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 113 Italy next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 114 Italy next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 115 Italy NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 116 Italy NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 117 Italy next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 118 Italy next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 119 Italy targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 120 Italy next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 121 Italy NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 122 Italy NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 123 Italy next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 124 Asia Pacific next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 125 Asia Pacific next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 126 Asia Pacific next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 127 Asia Pacific next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 128 Asia Pacific NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 129 Asia Pacific NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 130 Asia Pacific next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 131 Asia Pacific next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 132 Asia Pacific targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 133 Asia Pacific next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 134 Asia Pacific NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 135 Asia Pacific NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 136 Asia Pacific next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 137 Japan next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 138 Japan next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 139 Japan next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 140 Japan next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 141 Japan NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 142 Japan NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 143 Japan next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 144 Japan next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 145 Japan targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 146 Japan next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 147 Japan NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 148 Japan NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 149 Japan next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 150 China next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 151 China next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 152 China next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 153 China next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 154 China NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 155 China NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 156 China next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 157 China next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 158 China targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 159 China next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 160 China NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 161 China NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 162 China next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 163 India next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 164 India next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 165 India next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 166 India next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 167 India NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 168 India NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 169 India next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 170 India next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 171 India targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 172 India next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 173 India NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 174 India NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 175 India next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 176 South Korea next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 177 South Korea next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 178 South Korea next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 179 South Korea next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 180 South Korea NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 181 South Korea NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 182 South Korea next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 183 South Korea next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 184 South Korea targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 185 South Korea next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 186 South Korea NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 187 South Korea NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 188 South Korea next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 189 Australia next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 190 Australia next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 191 Australia next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 192 Australia next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 193 Australia NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 194 Australia NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 195 Australia next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 196 Australia next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 197 Australia targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 198 Australia next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 199 Australia NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 200 Australia NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 201 Australia next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 202 Latin America next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 203 Latin America next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 204 Latin America next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 205 Latin America next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 206 Latin America NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 207 Latin America NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 208 Latin America next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 209 Latin America next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 210 Latin America targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 211 Latin America next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 212 Latin America NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 213 Latin America NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 214 Latin America next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 215 Brazil next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 216 Brazil next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 217 Brazil next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 218 Brazil next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 219 Brazil NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 220 Brazil NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 221 Brazil next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 222 Brazil next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 223 Brazil targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 224 Brazil next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 225 Brazil NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 226 Brazil NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 227 Brazil next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 228 Mexico next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 229 Mexico next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 230 Mexico next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 231 Mexico next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 232 Mexico NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 233 Mexico NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 234 Mexico next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 235 Mexico next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 236 Mexico targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 237 Mexico next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 238 Mexico NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 239 Mexico NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 240 Mexico next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 241 MEA next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 242 MEA next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 243 MEA next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 244 MEA next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 245 MEA NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 246 MEA NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 247 MEA next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 248 MEA next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 249 MEA targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 250 MEA next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 251 MEA NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 252 MEA NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 253 MEA next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 254 South Africa next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 255 South Africa next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 256 South Africa next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 257 South Africa next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 258 South Africa NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 259 South Africa NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 260 South Africa next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 261 South Africa next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 262 South Africa targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 263 South Africa next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 264 South Africa NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 265 South Africa NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 266 South Africa next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 267 Saudi Arabia next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 268 Saudi Arabia next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 269 Saudi Arabia next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 270 Saudi Arabia next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 271 Saudi Arabia NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 272 Saudi Arabia NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 273 Saudi Arabia next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 274 Saudi Arabia next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 275 Saudi Arabia targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 276 Saudi Arabia next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 277 Saudi Arabia NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 278 Saudi Arabia NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 279 Saudi Arabia next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)

List of Figures
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain-based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary part-1
FIG. 8 Market summary part-2
FIG. 9 Generations of sequencing
FIG. 10 Different NGS technologies and type of analysis
FIG. 11 Common DNA sequencing methods
FIG. 12 Examples of NGS cost per sample
FIG. 13 Key end-users: NGS market
FIG. 14 Key end-users, by product: NGS market
FIG. 15 Comparison of next-generation sequencing technologies and Sanger sequencing
FIG. 16 Overview of sequencing technology timeline
FIG. 17 Key macroeconomic challenges associated with the pandemic
FIG. 18 Key elements to enhance the supply chain post-COVID
FIG. 19 Role of NGS to combat COVID-19 outbreak
FIG. 20 Workflow Comparison
FIG. 21 Market trends & outlook
FIG. 22 Market segmentation & scope
FIG. 23 Market driver relevance analysis (Current & future impact)
FIG. 24 Cost per raw megabase (Mb) of DNA sequence (USD)
FIG. 25 Cost per genome
FIG. 26 Expected rise in expenditure for cancer treatment (USD Billion)
FIG. 27 Global cancer prevalence
FIG. 28 Market restraint relevance analysis (Current & future impact)
FIG. 29 Percentage of NGS sequencing reimbursement from payers
FIG. 30 Bottlenecks associated with the implementation of NGS
FIG. 31 Penetration & growth prospect mapping for applications, 2021
FIG. 32 Penetration & growth prospect mapping for prominent industry players, 2021
FIG. 33 NGS platform penetration mapping, 2021
FIG. 34 Payer perspectives for developing coverage policy for Next-Generation Tumour Sequencing Panels (NGTS)
FIG. 35 Next generation sequencing market: Regional market share, 2021
FIG. 36 Next generation sequencing North America regulatory and political landscape analysis, 2021
FIG. 37 Next generation sequencing Europe regulatory and political landscape analysis, 2021
FIG. 38 Next generation sequencing Asia Pacific regulatory and political landscape analysis, 2021
FIG. 39 Next generation sequencing Latin America regulatory and political landscape analysis, 2021
FIG. 40 Next generation sequencing Middle East & Africa regulatory and political landscape analysis 2019
FIG. 41 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 42 Porter’s Five Forces Analysis
FIG. 43 Potentially actionable genes considered during the study
FIG. 44 Study results
FIG. 45 Company categorization
FIG. 46 Service providers, manufacturers, & suppliers of products
FIG. 47 Service providers
FIG. 48 Service providers
FIG. 49 Service providers
FIG. 50 NGS market share, by company, 2021 (%)
FIG. 51 Competitive dashboard analysis
FIG. 52 Regional distribution for private companies
FIG. 53 Penetration & growth prospect mapping for private companies, 2021
FIG. 54 Next generation sequencing market: Application outlook key takeaways
FIG. 55 Next generation sequencing market: Application movement analysis
FIG. 56 Global oncology market, 2018 - 2030 (USD Million)
FIG. 57 Diagnostics and screening market, 2018 - 2030 (USD Million)
FIG. 58 Oncology screening market, 2018 - 2030 (USD Million)
FIG. 59 Sporadic cancer screening market, 2018 - 2030 (USD Million)
FIG. 60 Inherited cancer screening market, 2018 - 2030 (USD Million)
FIG. 61 Companion diagnostics market, 2018 - 2030 (USD Million)
FIG. 62 Other diagnostics market, 2018 - 2030 (USD Million)
FIG. 63 Research studies market, 2018 - 2030 (USD Million)
FIG. 64 Global clinical investigation market, 2018 - 2030 (USD Million)
FIG. 65 Global infectious diseases market, 2018 - 2030 (USD Million)
FIG. 66 Global inherited diseases market, 2018 - 2030 (USD Million)
FIG. 67 Global idiopathic diseases market, 2018 - 2030 (USD Million)
FIG. 68 Global non-communicable/other diseases market, 2018 - 2030 (USD Million)
FIG. 69 Global reproductive health market, 2018 - 2030 (USD Million)
FIG. 70 Global NIPT market, 2018 - 2030 (USD Million)
FIG. 71 Global aneuploidy market, 2018 - 2030 (USD Million)
FIG. 72 Global microdeletions market, 2018 - 2030 (USD Million)
FIG. 73 Global NGS PGT market, 2018 - 2030 (USD Million)
FIG. 74 Global new-born/genetic screening market, 2018 - 2030 (USD Million)
FIG. 75 Single gene analysis market, 2018 - 2030 (USD Million)
FIG. 76 Global HLA typing/immune system monitoring market, 2018 - 2030 (USD Million)
FIG. 77 Global metagenomics, epidemiology & drug development market, 2018 - 2030 (USD Million)
FIG. 78 Global agrigenomics & forensics market, 2018 - 2030 (USD Million)
FIG. 79 Global consumer genomics market, 2018 - 2030 (USD Million)
FIG. 80 Next generation sequencing market: Technology outlook key takeaways
FIG. 81 Global next-generation sequencing market: Technology movement analysis
FIG. 82 Global whole genome sequencing market, 2018 - 2030 (USD Million)
FIG. 83 Global whole exome sequencing market, 2018 - 2030 (USD Million)
FIG. 84 Global targeted sequencing & resequencing market, 2018 - 2030 (USD Million)
FIG. 85 Global DNA-based targeted sequencing & resequencing market, 2018 - 2030 (USD Million)
FIG. 86 Global RNA-based targeted sequencing & resequencing market, 2018 - 2030 (USD Million)
FIG. 87 Next generation sequencing market Workflow outlook key takeaways
FIG. 88 Next generation sequencing market: Workflow movement analysis
FIG. 89 Global pre-sequencing market, 2018 - 2030 (USD Million)
FIG. 90 Global NGS library preparation kits market, 2018 - 2030 (USD Million)
FIG. 91 Global NGS semi-automated library preparation market, 2018 - 2030 (USD Million)
FIG. 92 Global NGS automated library preparation market, 2018 - 2030 (USD Million)
FIG. 93 Global clonal amplification market, 2018 - 2030 (USD Million)
FIG. 94 Global Sequencing market, 2018 - 2030 (USD Million)
FIG. 95 Global data analysis market, 2018 - 2030 (USD Million)
FIG. 96 Global NGS primary data analysis market, 2018 - 2030 (USD Million)
FIG. 97 Global NGS secondary data analysis market, 2018 - 2030 (USD Million)
FIG. 98 Global NGS tertiary data analysis market, 2018 - 2030 (USD Million)
FIG. 99 Next generation sequencing market End-use outlook key takeaways
FIG. 100 Next generation sequencing market: End-use movement analysis
FIG. 101 Global academic research market, 2018 - 2030 (USD Million)
FIG. 102 Global clinical research market, 2018 - 2030 (USD Million)
FIG. 103 Global hospitals & clinics market, 2018 - 2030 (USD Million)
FIG. 104 Global pharma & biotech entities market, 2018 - 2030 (USD Million)
FIG. 105 Global other users market, 2018 - 2030 (USD Million)
FIG. 106 Regional marketplace: Key takeaway
FIG. 107 Regional Sequencing Capacity Mapping
FIG. 108 Next generation regional outlook, 2019 & 2030
FIG. 109 Top players in North America
FIG. 110 Top players in Europe
FIG. 111 Top players in Asia Pacific
FIG. 112 Top players in Latin America and Middle East & Africa
FIG. 113 North America next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 114 U.S. next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 115 Canada next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 116 Europe next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 117 Germany next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 118 Spain next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 119 France next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 120 Italy next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 121 U.K. next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 122 Asia Pacific next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 123 Japan next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 124 China next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 125 India next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 126 Australia next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 127 South Korea next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 128 Latin America next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 129 Brazil next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 130 Mexico next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 131 Middle East & Africa. next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 132 South Africa next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 133 Saudi Arabia next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 134 Strategy framework
FIG. 135 Participant categorization
FIG. 136 Next-generation sequencing vendor’s landscape